BioNexus Gene Lab Corp Common stock (BGLC) Annual Income Statement (USD)
BGLC Quarterly Financials (USD)
Frequently Asked Questions About BioNexus Gene Lab Corp Common stock (BGLC) Stock
BioNexus Gene Lab Corp Common stock's (BGLC) last reported annual revenue was USD 9.77 Million.
BioNexus Gene Lab Corp Common stock's (BGLC) annual revenue growth rate based on the revenue reported in the past 5 years is : 115.07%
BioNexus Gene Lab Corp Common stock's(BGLC) is not profitable as of its last reported annual financials.
The net profit margin for BioNexus Gene Lab Corp Common stock's(BGLC) from its laster reported year is -26.91%
The return on equity (ROE) for BioNexus Gene Lab Corp Common stock's(BGLC) from its last reported annual financials is : -32.21%
The return on assets (ROA) for BioNexus Gene Lab Corp Common stock's(BGLC) from its last reported annual financials is : -16.10%
The return on invested capital (ROIC) for BioNexus Gene Lab Corp Common stock's(BGLC) from its last reported annual financials is : -32.04%
The Debt to Equity ratio for BioNexus Gene Lab Corp Common stock's(BGLC) from its last reported annual financials is : 0.00%
The dividend yield for BioNexus Gene Lab Corp Common stock's(BGLC) from its laster reported year is 0.00%
BioNexus Gene Lab Corp Common stock's(BGLC) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for BGLC !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
